These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6395283)

  • 41. [Contact activation of prekallikrein and plasminogen in plasma].
    Veremeenko KN; Volokhonskaia LI; Kizim AI; Pogorelaia NF
    Ukr Biokhim Zh (1978); 1983; 55(3):295-301. PubMed ID: 6553425
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of serine proteases in the blood coagulation cascade.
    Davie EW; Fujikawa K; Kurachi K; Kisiel W
    Adv Enzymol Relat Areas Mol Biol; 1979; 48():277-318. PubMed ID: 367103
    [No Abstract]   [Full Text] [Related]  

  • 43. The coagulation-kinin pathway of human plasma.
    Kaplan AP; Silverberg M
    Blood; 1987 Jul; 70(1):1-15. PubMed ID: 3297198
    [No Abstract]   [Full Text] [Related]  

  • 44. Contact systems in infectious disease.
    Colman RW
    Rev Infect Dis; 1989; 11 Suppl 4():S689-99. PubMed ID: 2665007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enzymological aspects of blood coagulation.
    Kisiel W; Fujikawa K
    Behring Inst Mitt; 1983 Aug; (73):29-42. PubMed ID: 6689603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A simple screening test for evaluating prolonged partial thromboplastin times in newborn infants.
    Andrew M; Karpatkin M
    J Pediatr; 1982 Oct; 101(4):610-2. PubMed ID: 7119968
    [No Abstract]   [Full Text] [Related]  

  • 47. Brasil factor. A new prekallikrein activator in human plasma.
    Webster ME; Stella RC; Villa ML; Toffoletto O
    Biochem Pharmacol; 1979 Sep; 28(18):2717-22. PubMed ID: 497023
    [No Abstract]   [Full Text] [Related]  

  • 48. Improved methods to assay contact activation.
    Soulier JP; Gozin D
    Adv Biosci; 1978 Jul; 17():271-80. PubMed ID: 755703
    [No Abstract]   [Full Text] [Related]  

  • 49. Mechanism of activation of the kallikrein-kinin system in plasma of patients with atopic allergic diseases.
    Dotsenko VL; Nenasheva NM; Neshkova EA; Morozova NA; Yarovaya GA
    Adv Exp Med Biol; 1989; 247B():515-21. PubMed ID: 2610090
    [No Abstract]   [Full Text] [Related]  

  • 50. Reduction of contact factors in sickle cell disease.
    Gordon EM; Klein BL; Berman BW; Strandjord SE; Simon JE; Coccia PF
    J Pediatr; 1985 Mar; 106(3):427-30. PubMed ID: 3844465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular assembly in the contact phase of the Hageman factor system.
    Cochrane CG; Griffin JH
    Am J Med; 1979 Oct; 67(4):657-64. PubMed ID: 386794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of purified human plasma prekallikrein triggered by cell wall fractions of Escherichia coli and Staphylococcus aureus.
    Kalter ES; van Dijk WC; Timmerman A; Verhoef J; Bouma BN
    J Infect Dis; 1983 Oct; 148(4):682-91. PubMed ID: 6355312
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced specificity of immunoblotting using radiolabeled antigen overlay: studies of blood coagulation factor XII and prekallikrein in plasma.
    Lämmle B; Berrettini M; Griffin JH
    Anal Biochem; 1986 Jul; 156(1):118-25. PubMed ID: 3638135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of high molecular weight kininogen in contact activation.
    van Iwaarden F; Bouma BN
    Semin Thromb Hemost; 1987 Jan; 13(1):15-24. PubMed ID: 2436301
    [No Abstract]   [Full Text] [Related]  

  • 55. The role of high molecular weight kininogen in contact activation of coagulation, fibrinolysis and kinin generation.
    Kaplan AP
    Adv Exp Med Biol; 1979; 120B():71-91. PubMed ID: 390992
    [No Abstract]   [Full Text] [Related]  

  • 56. Molecular mechanisms of fibrinolysis in man.
    Kaplan AP; Castellino FJ; Collen D; Wiman B; Taylor FB
    Thromb Haemost; 1978 Apr; 39(2):263-83. PubMed ID: 354080
    [No Abstract]   [Full Text] [Related]  

  • 57. Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease.
    Cordova C; Violi F; Alessandri C; Ferro D; Saliola M; Balsano F
    J Clin Pathol; 1986 Sep; 39(9):1003-5. PubMed ID: 3639088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new prekallikrein activator in human plasma which differs from Hageman factor and its fragments.
    Webster ME; Stella RC; Villa ML; Toffoletto O
    Adv Exp Med Biol; 1979; 120B():53-9. PubMed ID: 517247
    [No Abstract]   [Full Text] [Related]  

  • 59. Determination of prekallikrein using an amidolytic assay in plasma samples of critically ill patients.
    Kalter ES; Vlooswijk RA; Bouma BN
    Acta Chir Scand Suppl; 1982; 509():43-7. PubMed ID: 6962618
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunological studies of human Factor XI and prekallikrein: demonstration of complex formation with high molecular weight kininogen.
    Bouma BN; Vlooswijk RA; Griffin JH
    Adv Exp Med Biol; 1983; 156():109-13. PubMed ID: 6552836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.